MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-30-2025
AtriCure Retained Earnings 2011-2025 | ATRC
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings AtriCure
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -402 M | -357 M | -327 M | -280 M | -330 M | -282 M | -247 M | -226 M | -199 M | -166 M | -138 M | -122 M | -111 M | -103 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -103 M | -402 M | -235 M |
Quarterly Retained Earnings AtriCure
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -415 M | -409 M | -402 M | -386 M | -378 M | -370 M | -357 M | -347 M | -338 M | -333 M | -327 M | -322 M | - | -295 M | -280 M | -266 M | -364 M | -347 M | -330 M | -330 M | -330 M | -330 M | -282 M | -282 M | -282 M | -282 M | -247 M | -247 M | -247 M | -247 M | -226 M | -226 M | -226 M | -226 M | -199 M | -199 M | -199 M | -199 M | -166 M | -166 M | -166 M | -166 M | -138 M | -138 M | -138 M | -138 M | -122 M | -122 M | -122 M | -122 M | -111 M | -111 M | -111 M | -111 M | -103 M | -103 M | -103 M | -103 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -103 M | -415 M | -239 M |
Retained Earnings of other stocks in the Medical instruments industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Baxter International
BAX
|
14.9 B | $ 19.32 | 1.05 % | $ 9.85 B |  USA |
 |
Becton, Dickinson and Company
BDX
|
16.6 B | $ 196.18 | -0.01 % | $ 56.4 B | USA |
 |
Luminex Corporation
LMNX
|
83.8 M | - | - | $ 1.75 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
-250 M | $ 5.47 | -0.01 % | $ 110 M | USA |
 |
Akers Biosciences, Inc.
AKER
|
-120 M | - | -9.52 % | $ 20.6 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
-223 M | - | - | $ 955 M | USA |
 |
Harvard Bioscience
HBIO
|
-146 M | $ 0.71 | -1.78 % | $ 30.1 M | USA |
 |
Cantel Medical Corp.
CMD
|
548 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
-11.9 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
2.13 B | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
1.13 B | - | -0.02 % | $ 16.3 B | USA |
 |
Alcon
ALC
|
19.4 B | $ 80.33 | 0.26 % | $ 40.4 B |  Schweiz |
 |
Repro Med Systems
KRMD
|
-23.3 M | $ 6.25 | -3.55 % | $ 285 M | USA |
 |
iRhythm Technologies
IRTC
|
-759 M | $ 177.0 | 0.68 % | $ 5.52 B | USA |
 |
ICU Medical
ICUI
|
690 M | $ 148.17 | 0.81 % | $ 3.61 B | USA |
 |
LeMaitre Vascular
LMAT
|
145 M | $ 83.95 | -0.46 % | $ 1.88 B | USA |
 |
Atrion Corporation
ATRI
|
382 K | - | - | $ 810 M | USA |
 |
electroCore
ECOR
|
-165 M | $ 4.93 | 1.54 % | $ 27.2 K | USA |
 |
Isoray
ISR
|
-232 M | - | 0.03 % | $ 108 M | USA |
 |
AngioDynamics
ANGO
|
-429 M | $ 13.12 | -0.3 % | $ 536 M | USA |
 |
Merit Medical Systems
MMSI
|
696 M | $ 87.36 | -0.03 % | $ 5.09 B | USA |
 |
The Cooper Companies
COO
|
7.64 B | $ 82.55 | -0.03 % | $ 16.4 B | USA |
 |
Glaukos Corporation
GKOS
|
-599 M | $ 116.08 | -0.56 % | $ 5.62 B | USA |
 |
Haemonetics Corporation
HAE
|
352 M | $ 80.39 | 0.36 % | $ 4.05 B | USA |
 |
InfuSystem Holdings
INFU
|
-59.3 M | $ 8.93 | -1.71 % | $ 184 M | USA |
 |
Masimo Corporation
MASI
|
1.49 B | $ 132.7 | -0.44 % | $ 7.07 B | USA |
 |
OraSure Technologies
OSUR
|
-103 M | $ 2.43 | - | $ 181 M | USA |
 |
Intuitive Surgical
ISRG
|
6.8 B | $ 578.08 | 0.16 % | $ 205 B | USA |
 |
Microbot Medical
MBOT
|
-79.5 M | $ 2.16 | -0.88 % | $ 22 M |  Israel |
 |
Milestone Scientific
MLSS
|
-128 M | $ 0.29 | -1.41 % | $ 23.1 M | USA |
 |
Nephros
NEPH
|
-144 M | $ 4.98 | -4.78 % | $ 51.7 M | USA |
 |
STERIS plc
STE
|
2.48 B | $ 255.64 | 0.02 % | $ 25.2 B | USA |
 |
NeuroMetrix
NURO
|
-218 M | - | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
-487 M | $ 21.99 | -0.05 % | $ 3.79 B | USA |
 |
Predictive Oncology
POAI
|
-180 M | - | - | $ 32.4 M | USA |
 |
Pro-Dex
PDEX
|
35.9 M | $ 39.33 | -2.65 % | $ 129 M | USA |
 |
Utah Medical Products
UTMD
|
138 M | $ 56.66 | 0.66 % | $ 206 M | USA |
 |
Pulse Biosciences
PLSE
|
-337 M | $ 14.45 | -2.76 % | $ 694 M | USA |
 |
ResMed
RMD
|
3.61 B | $ 245.14 | 0.3 % | $ 35.8 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
-835 M | $ 11.47 | 3.66 % | $ 2.33 B | USA |
 |
Repligen Corporation
RGEN
|
433 M | $ 165.37 | -0.18 % | $ 9.21 M | USA |
 |
BioLife Solutions
BLFS
|
-335 M | $ 24.95 | -1.81 % | $ 1.15 B | USA |
 |
Stereotaxis
STXS
|
-538 M | $ 2.46 | 1.23 % | $ 199 M | USA |
 |
STAAR Surgical Company
STAA
|
-67.6 M | $ 23.37 | -1.1 % | $ 1.15 B | USA |
 |
Retractable Technologies
RVP
|
26.7 M | $ 0.82 | -0.51 % | $ 24.5 M | USA |
 |
Teleflex Incorporated
TFX
|
4.12 B | $ 122.75 | 0.7 % | $ 5.75 B | USA |
 |
West Pharmaceutical Services
WST
|
3.96 B | $ 274.28 | -0.95 % | $ 20 B | USA |